Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Drug misuse can cause serious eye infections and other severe side effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Valproic acid can cause muscle damage and liver issues, which improve after stopping the drug.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Cooling with antioxidants helps protect hair during chemotherapy.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Targeting ornithine decarboxylase can help prevent skin cancer.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

Posaconazole is a promising new treatment for toenail fungus.

Lithium can cause skin changes similar to mycosis fungoides.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.